Press release
Animal Vaccines Market Projected to Reach USD 36.46 Billion by 2034, Growing at a CAGR of 9.7%
Animal Vaccines Market
Market Introduction
Vaccines have been established as being advantageous for regulating illnesses in domestic animals. Their extensive usage has fiercely decreased the cases of grave and deadly diseases in companion animals. They have also sanctioned the reinforcement of livestock production, thus sanctioning profound escalation in animal-origin food and fiber production.
Animal vaccines have enhanced human health through the regulation of zoonotic illnesses such as rabies, brucellosis, and leptospirosis. In the absence of a rabies vaccine, many persons would not choose to domesticate companion animals in their homes. In the absence of potent vaccines for regulating prominent illnesses in food-producing animals, the obtainability of animal proteins for human intake would be greatly reduced.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/animal-vaccines-market/request-for-sample
Competitive Dynamics
The market is fragmented, with numerous players offering solutions across various industries. Some of the critical players in the market are mentioned below:
• Zoetis Inc.
• Merck & Co., Inc. (Merck Animal Health)
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Ceva Santé Animale
• Virbac
• Phibro Animal Health Corporation
• HIPRA
• Dechra Pharmaceuticals PLC
• Vetoquinol S.A.
Animal Vaccines Market Report Highlights
• The livestock segment holds the largest animal vaccines market share due to the high demand for vaccines to prevent diseases in farm animals, while the companion animal segment is registering the fastest growth driven by increasing pet ownership and awareness of pet healthcare.
• Attenuated live vaccines dominate the market due to their ability to provide long-lasting immunity with fewer doses. The recombinant vaccines segment is also growing the fastest, driven by innovations in biotechnology and safer vaccine formulations.
• Subcutaneous vaccines hold the largest animal vaccines market share due to their ease of administration, while the intranasal route is experiencing the fastest growth due to its non-invasive nature and effectiveness in preventing respiratory diseases.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/animal-vaccines-market/request-for-discount-pricing
Key Market Drivers
The growing existence of zoonotic illnesses is a notable driver in the market. Zoonotic illnesses that are imparted from animals to humans have been escalating, encouraging elevated concentration on prohibitive measures. As per the World Health Organization (WHO), roughly 60% of prevailing human communicable illnesses are zoonotic, and 76% of surfacing communicable illnesses have animal origin, thereby propelling the animal vaccines market growth.
The growing global demand for animal-derived food commodities such as meat, milk, and eggs is pushing the market demand. The Food and Agriculture Organization (FAO) predicts that worldwide meat production will escalate to roughly 15% by 2030.
Animal Vaccines Market Segmentation Analysis
The animal vaccines market segmentation is based on type, product, disease, route of administration, distribution channel, and region.
Based on type, the livestock vaccines segment dominated the market due to elevated demand for vaccines to prohibit illnesses in cattle, poultry, swine, and other farm animals. The requirement to sustain herd well-being and productivity, particularly because of the growing demand for animal-derived food commodities, has caused extensive acquisition of vaccines in the livestock sector.
Based on the product, the attenuated live vaccines segment is expected to grow at a higher rate due to the potential to offer robust, enduring immunity with lesser doses. Attenuated live vaccines are broadly utilized in both livestock and companion animals because of their ability to prevent a broad gamut of illnesses.
Global Animal Vaccines Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Animal Vaccines Market, by Type, 2020-2034 (USD Billion)
5.3. Livestock
5.3.1. Global Animal Vaccines Market, Livestock, by Region, 2020-2034 (USD Billion)
5.4. Companion
5.4.1. Global Animal Vaccines Market, by Companion, by Region, 2020-2034 (USD Billion)
Global Animal Vaccines Market, by Product
6.1. Key Findings
6.2. Introduction
6.2.1. Global Animal Vaccines Market, by Product, 2020-2034 (USD Billion)
6.3. Attenuated Live Vaccines
6.3.1. Global Animal Vaccines Market, by Attenuated Live Vaccines, by Region, 2020-2034 (USD Billion)
6.4. Inactivated Vaccines
6.4.1. Global Animal Vaccines Market, by Inactivated Vaccines, by Region, 2020-2034 (USD Billion)
6.5. Subunit Vaccines
6.5.1. Global Animal Vaccines Market, by Subunit Vaccines, by Region, 2020-2034 (USD Billion)
6.6. DNA Vaccines
6.6.1. Global Animal Vaccines Market, by DNA Vaccines, by Region, 2020-2034 (USD Billion)
6.7. Recombinant Vaccines
6.7.1. Global Animal Vaccines Market, by Recombinant Vaccines, by Region, 2020-2034 (USD Billion)
Global Animal Vaccines Market, by Disease
7.1. Key Findings
7.2. Introduction
7.2.1. Global Animal Vaccines Market, by Disease, 2020-2034 (USD Billion)
7.3. Swine Pneumonia
7.3.1. Global Animal Vaccines Market, by Swine Pneumonia, by Region, 2020-2034 (USD Billion)
7.4. Avian Influenza
7.4.1. Global Animal Vaccines Market, Avian Influenza, by Region, 2020-2034 (USD Billion)
7.5. Rabies
7.5.1. Global Animal Vaccines Market, Rabies, by Region, 2020-2034 (USD Billion)
7.6. Coccidiosis
7.6.1. Global Animal Vaccines Market, Coccidiosis, by Region, 2020-2034 (USD Billion)
7.7. Brucellosis
7.7.1. Global Animal Vaccines Market, Brucellosis, by Region, 2020-2034 (USD Billion)
7.8. Distemper
7.8.1. Global Animal Vaccines Market, Distemper, by Region, 2020-2034 (USD Billion)
7.9. Canine
7.9.1. Global Animal Vaccines Market, Canine, by Region, 2020-2034 (USD Billion)
7.10. Foot & Mouth
7.10.1. Global Animal Vaccines Market, Foot & Mouth, by Region, 2020-2034 (USD Billion)
7.11. Strangles
7.11.1. Global Animal Vaccines Market, Strangles, by Region, 2020-2034 (USD Billion)
Global Animal Vaccines Market, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.2.1. Global Animal Vaccines Market, by Route of Administration, 2020-2034 (USD Billion)
8.3. Subcutaneous
8.3.1. Global Animal Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Billion)
8.4. Intramuscular
8.4.1. Global Animal Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Billion)
8.5. Intranasal
8.5.1. Global Animal Vaccines Market, by Intranasal, by Region, 2020-2034 (USD Billion)
Global Animal Vaccines Market, by Distribution Channel
9.1. Key Findings
9.2. Introduction
9.2.1. Global Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Billion)
9.3. E-Commerce
9.3.1. Global Animal Vaccines Market, by E-Commerce, by Region, 2020-2034 (USD Billion)
9.4. Hospital/Clinic Pharmacy
9.4.1. Global Animal Vaccines Market, by Hospital/Clinic Pharmacy, by Region, 2020-2034 (USD Billion)
9.5. Others
9.5.1. Global Animal Vaccines Market, by Others, by Region, 2020-2034 (USD Billion)
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/animal-vaccines-market
Regional Insights
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
More Trending Latest Reports by Polaris Market Research:
E-Pharmacy Market
https://www.polarismarketresearch.com/industry-analysis/e-pharma-market
Viscosupplementation Market
https://www.polarismarketresearch.com/industry-analysis/viscosupplement-market
Leukemia Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/global-leukemia-therapeutics-market
Meningitis Diagnosis and Treatment Market
https://www.polarismarketresearch.com/industry-analysis/meningitis-diagnosis-treatment-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Animal Vaccines Market Projected to Reach USD 36.46 Billion by 2034, Growing at a CAGR of 9.7% here
News-ID: 3933729 • Views: …
More Releases from Polaris Market Research & Consulting
Lactation Support Supplements Market to Sail to US$ 1,209.90 Million With a 6.5% …
The lactation support supplements market is expected to gain market growth during the forecast period of 2025-2034. Polaris Market Research analyzes the market to account for USD 1,209.90 million by 2034 and is expected to register a CAGR of 6.5% in the above-mentioned forecast period. The market was valued at USD 643.04 million in 2024.
Market Overview:
Many modern parents who wish to benefit from breastfeeding strive to produce sufficient breast milk…
Autoinjectors Market is Expected to Register a CAGR of 14.3% Surging Towards US$ …
The autoinjectors market is expected to gain market growth during the forecast period of 2025 to 2034. Polaris Market Research analyzes the market to account for USD 31.20 billion by 2034 and is expected to register a CAGR of 14.3% in the above-mentioned forecast period. The market was valued at USD 8.22 billion in 2024.
Market Overview:
An autoinjector is a device designed to ease the self-administration of injectable medicines. By delivering…
Continuous Glucose Monitoring Device Market expected to reach USD 10.15 Billion …
The Continuous Glucose Monitoring Device Market Is Expected To Gain Market Growth During The Forecast Period Of 2025-2034. Polaris Market Research Analyses The Market To Account For USD 10.15 Billion By 2034 And Is Expected To Register A CAGR Of 7.0% In The Above-Mentioned Forecast Period. The Market Was Valued At USD 5.17 Billion In 2024.
Market Overview
A continuous glucose monitor (CGM) approximates what the glucose level is periodically and keeps…
Ovarian Cancer Market Projected to Reach USD 35.00 Billion by 2034, Growing at a …
The global ovarian cancer market was valued at USD 4.11 billion in 2024. It is expected to reach USD 35.00 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 24.1% from 2025 to 2034.
Market Preface:
Ovarian cancer is the uncontrolled growth of abnormal cells in the ovaries. The cells proliferate rapidly and can invade and destroy healthy body tissues. Ovarian cancer commences when cells in or proximity to ovaries…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market by Type - Livestock Vaccines and Companion Vac …
According to the report Global Veterinary Vaccines market, published by Market Data Forecast, The Global market has been estimated at USD 5507.3 Million in 2015 and is projected to reach USD 7197.82 Million by 2020, at a CAGR of 5.5% during the forecast period from 2015 to 2020. The Global veterinary vaccines market has seen significant growth over the past few years, due to fear of imminent epidemics that have…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
